Main > ONCOLOGY (**) > Kidney Cancer>RCC>MET *** > Treatment > DE. M. AveluMAb(1)+Axitinib(2)

---

DE. M. AveluMAb(1)+Axitinib(2)'s subsections
(*) EU Approval Date: 2019. 10.28.
(*) USA Approval Date: 2019. 05.15.
Companies
Patent(1)>Assignee; Claims; No.; ..
Patent(1)>Total USA No.: 2
Patent(1)>UpDate: 2019. 12.31.
TradeMark (1)
TradeMark (1) Web-Site
TradeMark (2)
TradeMark (2) Web-Site

DE. M. AveluMAb(1)+Axitinib(2)'s products
This section has no products